2025-12-21 · 个股论点

作者认为AAOI和POET虽具十倍潜力但因执行风险未去风险化，不属于高确信度标的。

涉及标的： $AAOI $ALAB $AMZN $COHR $MRVL $MSFT $NBIS $POET

中文翻译

对我个人而言：当一家公司在根本上已“去风险化(de-risked)”并正从该点迈向规模化时，我才视其为“高确信度(high conviction)”标的。例如，$NBIS 在与微软达成交易后。在光子学(photonics)领域，我个人更看好 $AAOI 而非 $POET。但它们都尚未“去风险化”。正如你提到的，Poet 受益于 Celestial（已被 $MRVL 收购）。Marvell 基本上通过 Celestial 向超大规模云厂商(hyperscalers)出售 Poet 的中介层(interposer)，用于连接 TPU/Trainium。但这中间隔着多层环节。 $AAOI 已经拥有与超大规模云厂商的直接合同，例如与 $AMZN 合作 Trainium，与 $MSFT 合作 Maia。此外还有类似 $ALAB 与亚马逊那样的股权协议。然而，它们实现了完全垂直整合且工厂建在德克萨斯州。如果能让整个供应链在美国实现规模化并完美执行，它们有巨大的10倍增长潜力。但由于相比 $COHR 规模较小，$AAOI 存在巨大的执行风险，因此不属于高确信度标的。$POET 同理，目前尚无让我完全确信的去风险化因素。不过，Poet 和 AAOI 都是具备10倍潜力的光子学标的，这也是我持仓部分 $AAOI 的原因，但它们都不属于高确信度投资。

英文原文

For me personally: A stock is "high conviction" when they are fundamentally de-risked and are going from that point to scale. For example, $NBIS post-MSFT deal. I like $AAOI much better than $POET in the photonics space personally. But neither of them are "de-risked yet". So Poet as you mentioned, benefits from Celestial, which got acquired $MRVL. Marvell basically sells Poet's interposer via Celestial to hyperscalers for connecting tpus/trainium. But this is via multiple hops away. $AAOI already had direct hyperscaler contracts like $AMZN for Trainium + $MSFT for Maia. And equity agreements like what $ALAB has for Amazon. However, they're fully vertically integrated + built in Texas. They have a pretty big potential to 10X if they can get the whole supply chain to scale in America + perfect execution. But because they're at lower scale compared to $COHR, $AAOI has huge execution risk + it's not high-conviction. Same with $POET, there's no de-risking factor yet that would make me fully convinced. However, Poet and AAOI are both photonics plays that can 10x, which is why I have some $AAOI in my portfolio, but neither are high conviction.

在 X 上查看原推 ↗